Healthcare & Biotech
Sequence Bio
Discovering the true signals of disease to power life-changing drugs.
90% of drug candidates fail, delaying help for those in need. We’re on a mission to change that. Better drug target discovery powered by the Newfoundland founder effect.
- Drug Discovery and Delivery
- Genomics
- Therapeutics
- Website
- sequencebio.com
- Headquarters
- St. John's, NL, Canada
- Team size
- 51-200 people
- Founded
- 2019
- Demo
- 30 min demo
Similar companies
Talus BioDiscovering drugs that target the DNA regulome
Arpeggio BioArpeggio Bio develops drugs targeting transcription factors using AI…
Ochre BioRNA medicines for liver diseases
Gilgamesh PharmaceuticalsGilgamesh Pharmaceuticals, a Clinical stage biotechnology company…
Uncommon TherapeuticsA Disease Focused Biotech, Building Multiple Billion Dollar Drugs
Eris BiotechOur drugs engage the immune system to fight tumors
Ditto BiosciencesEvolutionary intelligence for autoimmune disease
Origami Therapeutics, Inc.Oral drugs to halt neurodegeneration